Skip to main content

previous disabled Page of 5
and
  1. No Access

    Article

    Semiautomated approach focused on new genomic information results in time and effort-efficient reannotation of negative exome data

    Most rare disease patients (75–50%) undergoing genomic sequencing remain unsolved, often due to lack of information about variants identified. Data review over time can leverage novel information regarding dis...

    Alejandro Ferrer, Patrick Duffy, Rory J. Olson, Michael A. Meiners in Human Genetics (2024)

  2. Article

    Open Access

    From periphery immunity to central domain through clinical interview as a new insight on schizophrenia

    Identifying disease predictors through advanced statistical models enables the discovery of treatment targets for schizophrenia. In this study, a multifaceted clinical and laboratory analysis was conducted, in...

    Wirginia Krzyściak, Marta Szwajca, Natalia Śmierciak, Robert Chrzan in Scientific Reports (2024)

  3. Article

    Open Access

    Congenital disorders of glycosylation: narration of a story through its patents

    Congenital disorders of glycosylation are a group of more than 160 rare genetic defects in protein and lipid glycosylation. Since the first clinical report in 1980 of PMM2-CDG, the most common CDG worldwide, r...

    Maria Monticelli, Tania D’Onofrio, Jaak Jaeken in Orphanet Journal of Rare Diseases (2023)

  4. No Access

    Article

    Pathogenic DDOST Variant Is Associated with Humoral Immune Deficiency

    Andrea Sitek, Anna Ligezka, Rohit Budhraja, Eva Morava in Journal of Clinical Immunology (2023)

  5. Article

    Open Access

    Antidepressants that increase mitochondrial energetics may elevate risk of treatment-emergent mania

    Preclinical evidence suggests that antidepressants (ADs) may differentially influence mitochondrial energetics. This study was conducted to investigate the relationship between mitochondrial function and illne...

    Manuel Gardea-Resendez, Brandon J. Coombes, Marin Veldic in Molecular Psychiatry (2023)

  6. Article

    Open Access

    Galactose epimerase deficiency: lessons from the GalNet registry

    Galactose epimerase (GALE) deficiency is a rare hereditary disorder of galactose metabolism with only a few cases described in the literature. This study aims to present the data of patients with GALE deficien...

    Britt Derks, Didem Demirbas, Rodrigo R. Arantes in Orphanet Journal of Rare Diseases (2022)

  7. No Access

    Chapter

    Congenital Disorders of Glycosylation, Dolichol and Glycosylphosphatidylinositol Metabolism

    Numerous proteins are glycosylated with monosaccharides and/or oligosaccharide structures, also termed glycans, attached to the polypeptide chain. Most extracellular proteins, such as serum proteins, most memb...

    Jaak Jaeken, Eva Morava in Inborn Metabolic Diseases (2022)

  8. No Access

    Chapter

    Disorders of the Pyruvate Metabolism and the Krebs Cycle

    This chapter focuses on pyruvate metabolism disorders, two classic Krebs cycle disorders (2-oxoglutaric aciduria and fumarase deficiency) and two other disorders of the Krebs cycle, severely affecting mitochon...

    Eva Morava, Linda de Meirleir in Physician's Guide to the Diagnosis, Treatm… (2022)

  9. Article

    Open Access

    Early-adolescent antibiotic exposure results in mitochondrial and behavioral deficits in adult male mice

    Exposure to antibiotic treatment has been associated with increased vulnerability to various psychiatric disorders. However, a research gap exists in understanding how adolescent antibiotic therapy affects beh...

    Anouk C. Tengeler, Tim L. Emmerzaal, Bram Geenen, Vivienne Verweij in Scientific Reports (2021)

  10. Article

    Open Access

    D-galactose supplementation in individuals with PMM2-CDG: results of a multicenter, open label, prospective pilot clinical trial

    PMM2-CDG is the most prevalent congenital disorder of glycosylation (CDG) with only symptomatic therapy. Some CDG have been successfully treated with D-galactose. We performed an open-label pilot trial with D-...

    Peter Witters, Hans Andersson, Jaak Jaeken in Orphanet Journal of Rare Diseases (2021)

  11. Article

    Open Access

    Spontaneous improvement of carbohydrate-deficient transferrin in PMM2-CDG without mannose observed in CDG natural history study

    A recent report on long-term dietary mannose supplementation in phosphomannomutase 2 deficiency (PMM2-CDG) claimed improved glycosylation and called for double-blind randomized study of the dietary supplement ...

    Peter Witters, Andrew C. Edmondson, Christina Lam in Orphanet Journal of Rare Diseases (2021)

  12. Article

    Open Access

    Liver manifestations in a cohort of 39 patients with congenital disorders of glycosylation: pin-pointing the characteristics of liver injury and proposing recommendations for follow-up

    The congenital disorders of glycosylation (CDG) are a heterogeneous group of rare metabolic diseases with multi-system involvement. The liver phenotype of CDG varies not only according to the specific disorder...

    Rodrigo Tzovenos Starosta, Suzanne Boyer, Shawn Tahata in Orphanet Journal of Rare Diseases (2021)

  13. Article

    Open Access

    Impaired mitochondrial complex I function as a candidate driver in the biological stress response and a concomitant stress-induced brain metabolic reprogramming in male mice

    Mitochondria play a critical role in bioenergetics, enabling stress adaptation, and therefore, are central in biological stress responses and stress-related complex psychopathologies. To investigate the effect...

    Tim L. Emmerzaal, Graeme Preston, Bram Geenen, Vivienne Verweij in Translational Psychiatry (2020)

  14. No Access

    Article

    Elevated sorbitol underlies a heritable neuropathy

    A new study identifies sorbitol dehydrogenase (SORD) deficiency as a slowly progressive hereditary motor axonopathy caused by a genetic defect in the second step of the polyol pathway, thus leading to elevated...

    Eva Morava in Nature Genetics (2020)

  15. No Access

    Article

    Liver involvement in kidney disease and vice versa

    The liver and kidneys are often similarly affected by a single disease. This is the case in metabolic, immunological, toxic, and infectious diseases, and in the different congenital malformation syndromes. Als...

    Karen Van Hoeve, Djalila Mekahli, Eva Morava, Elena Levtchenko in Pediatric Nephrology (2018)

  16. No Access

    Article

    Recognizable phenotypes in CDG

    Pattern recognition, using a group of characteristic, or discriminating features, is a powerful tool in metabolic diagnostic. A classic example of this approach is used in biochemical analysis of urine organic...

    Carlos R. Ferreira, Ruqaia Altassan in Journal of Inherited Metabolic Disease (2018)

  17. No Access

    Book

  18. No Access

    Chapter

    Secondary Hemophagocytic Syndrome Associated with COG6 Gene Defect: Report and Review

    Hemophagocytic lymphohistiocytosis (HLH) is a rare but potentially fatal disease that is characterized by proliferation and infiltration of hyperactivated macrophages and T-lymphocytes. Clinically, it is chara...

    Nouf Althonaian, Abdulrahman Alsultan, Eva Morava in JIMD Reports, Volume 42 (2018)

  19. Article

    Open Access

    Public and patient involvement in needs assessment and social innovation: a people-centred approach to care and research for congenital disorders of glycosylation

    Public and patient involvement in the design of people-centred care and research is vital for communities whose needs are underserved, as are people with rare diseases. Innovations devised collectively by pati...

    Cláudia de Freitas, Vanessa dos Reis, Susana Silva in BMC Health Services Research (2017)

  20. No Access

    Book

previous disabled Page of 5